Abstract:C omplete tumor resection is of utmost importance and a cornerstone in the treatment of numerous tumors; it is the aim of every surgeon. Surgery might be followed by adjuvant therapy to complete this task, but it still may fail as a result of limited recognition of tumor cells at the resection site. An incomplete tumor resection is at risk of tumor recurrence regardless of adjuvant therapies, and recurrence decreases quality of life and shortens life expectancy. Tumor diagnosis and intraoperative definition of tumor borders are based on various visualization methods and on the histopathological examination of a limited number of biopsy specimens via frozen sections. Today, gold standard surgical visualization tools include surgical “microscopes,” laparoscopes, ultrasonography, intraoperative magnetic resonance imaging, and computed tomography, as well as more sophisticated navigation devices. None of these is able to differentiate tumor from normal tissue at a cellular level, which is necessary to achieve higher accuracy in surgical tumor therapy, especially for malignant tumors. Therefore, frozen sections are typically used to define and differentiate tumor cells ex vivo. Normally, they are removed when the tumor is exposed but not yet resected. Unfortunately, intraoperative histopathology has several shortcomings, and many biopsies are inconclusive. First, the tissue architecture of the tumor can be altered during specimen preparation and can be mechanically destroyed. In addition, sampling errors are possible as a result of tissue heterogeneity. Finally, the lack of realtime interactivity with the pathologist and the waiting time of about 30 minutes for the result disrupt the surgical workflow. According to our own surgical experiences, we can say that optimal surgical therapy includes a combination of maximal resection of diseased tissue with minimal damage to the normal tissue. This can be achieved only with the ability to identify intraoperative cellular structures and to differentiate tumor from normal functional tissue. This opinion assumes the need for new technological equipment integrated within new surgical concepts. Confocal laser endomicroscopy (CLE) is an imaging technique that provides microscopic information of tissue in real time. Instead of taking a tissue sample from a patient and bringing it under the microscope for analysis, these “optical biopsies” bring the microscope inside the patient through miniaturized fiberoptic probes and allow real-time histopathology with a resolution down to 1 mm. A clear visualization of the cytoarchitecture of the cell can be achieved with a 1000fold magnification. CLE was introduced in 2004 in gastroenterology as a supplement to the current standard endoscopy for performing optical biopsies. It is also currently becoming a useful diagnostic tool in urology, pulmonology, and gynecology. We investigated the use of CLE in our neurosurgical treatment to analyze the technical considerations. Furthermore, we investigated the integration of CLE in the neurosurgical daily workflow in the operation room as an ex vivo diagnostic module, and we tried to create an easy integration of the CLE technique into the neurosurgical daily routine using endoscopic or microscopic settings and providing immediate intraoperative histopathological diagnosis of the entire entity in real time.We also investigated the best conditions for an evaluation of CLE for in vivo diagnosis in different types and models of intracranial and intraspinal neoplasia. Our results are reported here.

Laser fluorescence spectroscopy in surgical treatment of intramedullary tumors: experience of the Burdenko Neurosurgery Center

Laser biospectroscopy and 5-ALA fluorescence navigation as a helpful tool in the meningioma resection

144 Use of Intraoperative Sodium Fluorescein During Nerve Tumor Surgery: A Systematic Review

Comparison of Effectiveness, Feasibility, Indications, and Limitations of Different Intraoperative Dyes in Spinal Neuro-Oncologic Surgery. A Systematic Review

Fluorescein-guided Surgery for Spinal Gliomas: Analysis of 220 Consecutive Cases.

Intraoperative Fluorescence Redefining Neurosurgical Precision.

In Situ Light-Source Delivery During 5-Aminulevulinic Acid-Guided High-Grade Glioma Resection: Spatial, Functional and Oncological Informed Surgery

Intraoperative application of yellow fluorescence in resection of intramedullary spinal canal ependymoma

Fluorescein Application in Cranial and Spinal Tumors Enhancing at Preoperative MRI and Operated With a Dedicated Filter on the Surgical Microscope: Preliminary Results in 279 Patients Enrolled in the FLUOCERTUM Prospective Study

An integrated diagnosis and therapeutic system using intra-operative 5-aminolevulinic-acid-induced fluorescence guided robotic laser ablation for precision neurosurgery

Intraoperative confocal laser endomicroscopy during 5-aminolevulinic acid-guided glioma surgery: significant considerations for resection at the tumor margin

Fluorescence-Guided Surgical Techniques in Adult Diffuse Low-Grade Gliomas: State-of-the-Art and Emerging Techniques: A Systematic Review

Single-Center Experience of Resection of 120 Cases of Intradural Spinal Tumors

Ex Vivo Classification of Spinal Cord Tumors Using Autofluorescence Spectroscopy and Immunohistochemical Indexes

Enhancing Glioblastoma Resection with NIR Fluorescence Imaging: A Systematic Review

Optical Brain Biopsy with a Fluorescence and Vessel Tracing Probe

Confocal Laser Endomicroscopy for Real-time Histomorphological Diagnosis: Our Clinical Experience With 150 Brain and Spinal Tumor Cases.

Combination of intraoperative 5-aminolevulinic acid-induced fluorescence and 3-D MR imaging for guidance of robotic laser ablation for precision neurosurgery.

Sodium-fluorescein-guided awake surgery for cerebral metastases located in eloquent brain areas: technical notes and preliminary experiences

Application of a Scanner-Assisted Carbon Dioxide Laser System for Neurosurgery

Application of Intra-Operative Yellow Fluorescence to Intramedullary Spinal Cord Ependymoma Resection